Upregulation of ANXA1 has been observed in lung cancer, pancreatic cancer, colorectal cancer, and melanomas, and has a notable correlation with advanced stages and unfavorable prognosis [19, 23, 31–33]. This evidence concerns the gene ANXA1 and familial pancreatic carcinoma.